Are We There Yet? How and When Specific Biotechnologies Will Improve Human Health

Elizabeth O'Day; Leticia  Hosta‐Rigau; Diego Oyarzun; Hideyuki  Okano; Víctor de Lorenzo; Conrad von Kameke; Habiba  Alsafar; Cong  Cao; Guo-Qiang Chen; Weizhi  Ji; Richard J. Roberts; Mostafa Ronaghi; Karen  Yeung; Feng Zhang; Sang Yup  Lee

doi:10.1002/biot.201800195

Are We There Yet? How and When Specific Biotechnologies Will Improve Human Health

Elizabeth O'Day, Leticia Hosta‐Rigau, Diego Oyarzun, Hideyuki Okano, Víctor de Lorenzo, Conrad von Kameke, Habiba Alsafar, Cong Cao, Guo-Qiang Chen, Weizhi Ji , Richard J. Roberts, Mostafa Ronaghi, Karen Yeung, Feng Zhang, Sang Yup Lee

Research output: Contribution to journal › Article › peer-review

Abstract / Description of output

Patient X: A 67‐year‐old Caucasian man slips on a patch of ice. He has abrasions to his hands and has sustained significant damage to his hip. At the emergency room, he informs clinicians he takes atorvastatin, metformin, and glimepiride to treat hypertension and Type 2 Diabetes Mellitus (T2DM). X‐rays reveal a fractured hip, which will require total hip replacement surgery.

Original language	English
Pages (from-to)	1-11
Number of pages	11
Journal	Biotechnology Journal
Volume	14
Issue number	1
Early online date	24 May 2018
DOIs	https://doi.org/10.1002/biot.201800195
Publication status	Published - 10 Jan 2019

Keywords / Materials (for Non-textual outputs)

biotechnology
gene editing
precision medicine
stem cells
tissue engineering

Access to Document

10.1002/biot.201800195

https://onlinelibrary.wiley.com/doi/full/10.1002/biot.201800195

Cite this

@article{211c9039a78f47be858f2134aff9cf88,

title = "Are We There Yet? How and When Specific Biotechnologies Will Improve Human Health",

abstract = "Patient X: A 67‐year‐old Caucasian man slips on a patch of ice. He has abrasions to his hands and has sustained significant damage to his hip. At the emergency room, he informs clinicians he takes atorvastatin, metformin, and glimepiride to treat hypertension and Type 2 Diabetes Mellitus (T2DM). X‐rays reveal a fractured hip, which will require total hip replacement surgery.",

keywords = "biotechnology, gene editing, precision medicine, stem cells, tissue engineering",

author = "Elizabeth O'Day and Leticia Hosta‐Rigau and Diego Oyarzun and Hideyuki Okano and {de Lorenzo}, V{\'i}ctor and {von Kameke}, Conrad and Habiba Alsafar and Cong Cao and Guo-Qiang Chen and Weizhi Ji and Roberts, {Richard J.} and Mostafa Ronaghi and Karen Yeung and Feng Zhang and Lee, {Sang Yup}",

year = "2019",

month = jan,

day = "10",

doi = "10.1002/biot.201800195",

language = "English",

volume = "14",

pages = "1--11",

journal = "Biotechnology Journal",

issn = "1860-6768",

publisher = "Wiley",

number = "1",

}

TY - JOUR

T1 - Are We There Yet? How and When Specific Biotechnologies Will Improve Human Health

AU - O'Day, Elizabeth

AU - Hosta‐Rigau, Leticia

AU - Oyarzun, Diego

AU - Okano, Hideyuki

AU - de Lorenzo, Víctor

AU - von Kameke, Conrad

AU - Alsafar, Habiba

AU - Cao, Cong

AU - Chen, Guo-Qiang

AU - Ji , Weizhi

AU - Roberts, Richard J.

AU - Ronaghi, Mostafa

AU - Yeung, Karen

AU - Zhang, Feng

AU - Lee, Sang Yup

PY - 2019/1/10

Y1 - 2019/1/10

N2 - Patient X: A 67‐year‐old Caucasian man slips on a patch of ice. He has abrasions to his hands and has sustained significant damage to his hip. At the emergency room, he informs clinicians he takes atorvastatin, metformin, and glimepiride to treat hypertension and Type 2 Diabetes Mellitus (T2DM). X‐rays reveal a fractured hip, which will require total hip replacement surgery.

AB - Patient X: A 67‐year‐old Caucasian man slips on a patch of ice. He has abrasions to his hands and has sustained significant damage to his hip. At the emergency room, he informs clinicians he takes atorvastatin, metformin, and glimepiride to treat hypertension and Type 2 Diabetes Mellitus (T2DM). X‐rays reveal a fractured hip, which will require total hip replacement surgery.

KW - biotechnology

KW - gene editing

KW - precision medicine

KW - stem cells

KW - tissue engineering

UR - https://spiral.imperial.ac.uk/handle/10044/1/60871

U2 - 10.1002/biot.201800195

DO - 10.1002/biot.201800195

M3 - Article

C2 - 29799175

SN - 1860-6768

VL - 14

SP - 1

EP - 11

JO - Biotechnology Journal

JF - Biotechnology Journal

IS - 1

ER -

Are We There Yet? How and When Specific Biotechnologies Will Improve Human Health

Abstract / Description of output

Keywords / Materials (for Non-textual outputs)

Access to Document

Other files and links

Fingerprint

Cite this